Report Detail

Request for Sample of this report

Pharma & Healthcare Global Large Volume Parenteral (LVP) Sales Market Report 2021

  • RnM2306867
    • |
  • 19 April, 2021
    • |
  • Global
    • |
  • 148 Pages
    • |
  • QYResearch
    • |
  • Pharma & Healthcare

The global Large Volume Parenteral (LVP) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Large Volume Parenteral (LVP) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Soft Bag LVP
Plastic Bottle LVP
Glass Bottle LVP
In 2018, Soft Bag LVP accounted for a major share of 61% in the global Large Volume Parenteral (LVP) market. And this product segment is poised to reach 15402 M Units by 2024 from 13868 M Units in 2019.

Segment by Application
Basic Infusion
Therapeutic Infusion
Nutritious Infusion

The Large Volume Parenteral (LVP) market is analysed and market size information is provided by regions (countries). Segment by Application, the Large Volume Parenteral (LVP) market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Baxter Healthcare
Kelun Pharma
B. Braun
Fresenius
Teva Pharmaceutical Industries
Pfizer (Hospira)
Ostuka Pharmaceutical
CR Double-Crane
Pisa
Huaren
Patheon
Aspen Holdings
Beximco Pharma
Cook Pharmica
Albert David
PSI Ltd
Ozon Pharmaceuticals
BAG Healthcare
BML Parenteral Drugs


1 Large Volume Parenteral (LVP) Market Overview

  • 1.1 Large Volume Parenteral (LVP) Product Scope
  • 1.2 Large Volume Parenteral (LVP) Segment by Type
    • 1.2.1 Global Large Volume Parenteral (LVP) Sales by Type (2016 & 2021 & 2027)
    • 1.2.2 Soft Bag LVP
    • 1.2.3 Plastic Bottle LVP
    • 1.2.4 Glass Bottle LVP
  • 1.3 Large Volume Parenteral (LVP) Segment by Application
    • 1.3.1 Global Large Volume Parenteral (LVP) Sales Comparison by Application (2016 & 2021 & 2027)
    • 1.3.2 Basic Infusion
    • 1.3.3 Therapeutic Infusion
    • 1.3.4 Nutritious Infusion
  • 1.4 Large Volume Parenteral (LVP) Market Estimates and Forecasts (2016-2027)
    • 1.4.1 Global Large Volume Parenteral (LVP) Market Size in Value Growth Rate (2016-2027)
    • 1.4.2 Global Large Volume Parenteral (LVP) Market Size in Volume Growth Rate (2016-2027)
    • 1.4.3 Global Large Volume Parenteral (LVP) Price Trends (2016-2027)

2 Large Volume Parenteral (LVP) Estimates and Forecasts by Region

  • 2.1 Global Large Volume Parenteral (LVP) Market Size by Region: 2016 VS 2021 VS 2027
  • 2.2 Global Large Volume Parenteral (LVP) Retrospective Market Scenario by Region (2016-2021)
    • 2.2.1 Global Large Volume Parenteral (LVP) Sales Market Share by Region (2016-2021)
    • 2.2.2 Global Large Volume Parenteral (LVP) Revenue Market Share by Region (2016-2021)
  • 2.3 Global Large Volume Parenteral (LVP) Market Estimates and Forecasts by Region (2022-2027)
    • 2.3.1 Global Large Volume Parenteral (LVP) Sales Estimates and Forecasts by Region (2022-2027)
    • 2.3.2 Global Large Volume Parenteral (LVP) Revenue Forecast by Region (2022-2027)
  • 2.4 Geographic Market Analysis: Market Facts & Figures
    • 2.4.1 North America Large Volume Parenteral (LVP) Estimates and Projections (2016-2027)
    • 2.4.2 Europe Large Volume Parenteral (LVP) Estimates and Projections (2016-2027)
    • 2.4.3 China Large Volume Parenteral (LVP) Estimates and Projections (2016-2027)
    • 2.4.4 Japan Large Volume Parenteral (LVP) Estimates and Projections (2016-2027)
    • 2.4.5 Southeast Asia Large Volume Parenteral (LVP) Estimates and Projections (2016-2027)
    • 2.4.6 India Large Volume Parenteral (LVP) Estimates and Projections (2016-2027)

3 Global Large Volume Parenteral (LVP) Competition Landscape by Players

  • 3.1 Global Top Large Volume Parenteral (LVP) Players by Sales (2016-2021)
  • 3.2 Global Top Large Volume Parenteral (LVP) Players by Revenue (2016-2021)
  • 3.3 Global Large Volume Parenteral (LVP) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Large Volume Parenteral (LVP) as of 2020)
  • 3.4 Global Large Volume Parenteral (LVP) Average Price by Company (2016-2021)
  • 3.5 Manufacturers Large Volume Parenteral (LVP) Manufacturing Sites, Area Served, Product Type
  • 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Large Volume Parenteral (LVP) Market Size by Type

  • 4.1 Global Large Volume Parenteral (LVP) Historic Market Review by Type (2016-2021)
    • 4.1.1 Global Large Volume Parenteral (LVP) Sales Market Share by Type (2016-2021)
    • 4.1.2 Global Large Volume Parenteral (LVP) Revenue Market Share by Type (2016-2021)
    • 4.1.3 Global Large Volume Parenteral (LVP) Price by Type (2016-2021)
  • 4.2 Global Large Volume Parenteral (LVP) Market Estimates and Forecasts by Type (2022-2027)
    • 4.2.1 Global Large Volume Parenteral (LVP) Sales Forecast by Type (2022-2027)
    • 4.2.2 Global Large Volume Parenteral (LVP) Revenue Forecast by Type (2022-2027)
    • 4.2.3 Global Large Volume Parenteral (LVP) Price Forecast by Type (2022-2027)

5 Global Large Volume Parenteral (LVP) Market Size by Application

  • 5.1 Global Large Volume Parenteral (LVP) Historic Market Review by Application (2016-2021)
    • 5.1.1 Global Large Volume Parenteral (LVP) Sales Market Share by Application (2016-2021)
    • 5.1.2 Global Large Volume Parenteral (LVP) Revenue Market Share by Application (2016-2021)
    • 5.1.3 Global Large Volume Parenteral (LVP) Price by Application (2016-2021)
  • 5.2 Global Large Volume Parenteral (LVP) Market Estimates and Forecasts by Application (2022-2027)
    • 5.2.1 Global Large Volume Parenteral (LVP) Sales Forecast by Application (2022-2027)
    • 5.2.2 Global Large Volume Parenteral (LVP) Revenue Forecast by Application (2022-2027)
    • 5.2.3 Global Large Volume Parenteral (LVP) Price Forecast by Application (2022-2027)

6 North America Large Volume Parenteral (LVP) Market Facts & Figures

  • 6.1 North America Large Volume Parenteral (LVP) Sales by Company
    • 6.1.1 North America Large Volume Parenteral (LVP) Sales by Company (2016-2021)
    • 6.1.2 North America Large Volume Parenteral (LVP) Revenue by Company (2016-2021)
  • 6.2 North America Large Volume Parenteral (LVP) Sales Breakdown by Type
    • 6.2.1 North America Large Volume Parenteral (LVP) Sales Breakdown by Type (2016-2021)
    • 6.2.2 North America Large Volume Parenteral (LVP) Sales Breakdown by Type (2022-2027)
  • 6.3 North America Large Volume Parenteral (LVP) Sales Breakdown by Application
    • 6.3.1 North America Large Volume Parenteral (LVP) Sales Breakdown by Application (2016-2021)
    • 6.3.2 North America Large Volume Parenteral (LVP) Sales Breakdown by Application (2022-2027)

7 Europe Large Volume Parenteral (LVP) Market Facts & Figures

  • 7.1 Europe Large Volume Parenteral (LVP) Sales by Company
    • 7.1.1 Europe Large Volume Parenteral (LVP) Sales by Company (2016-2021)
    • 7.1.2 Europe Large Volume Parenteral (LVP) Revenue by Company (2016-2021)
  • 7.2 Europe Large Volume Parenteral (LVP) Sales Breakdown by Type
    • 7.2.1 Europe Large Volume Parenteral (LVP) Sales Breakdown by Type (2016-2021)
    • 7.2.2 Europe Large Volume Parenteral (LVP) Sales Breakdown by Type (2022-2027)
  • 7.3 Europe Large Volume Parenteral (LVP) Sales Breakdown by Application
    • 7.3.1 Europe 148 Sales Breakdown by Application (2016-2021)
    • 7.3.2 Europe 148 Sales Breakdown by Application (2022-2027)

8 China Large Volume Parenteral (LVP) Market Facts & Figures

  • 8.1 China Large Volume Parenteral (LVP) Sales by Company
    • 8.1.1 China Large Volume Parenteral (LVP) Sales by Company (2016-2021)
    • 8.1.2 China Large Volume Parenteral (LVP) Revenue by Company (2016-2021)
  • 8.2 China Large Volume Parenteral (LVP) Sales Breakdown by Type
    • 8.2.1 China Large Volume Parenteral (LVP) Sales Breakdown by Type (2016-2021)
    • 8.2.2 China Large Volume Parenteral (LVP) Sales Breakdown by Type (2022-2027)
  • 8.3 China Large Volume Parenteral (LVP) Sales Breakdown by Application
    • 8.3.1 China 316 Sales Breakdown by Application (2016-2021)
    • 8.3.2 China 316 Sales Breakdown by Application (2022-2027)

9 Japan Large Volume Parenteral (LVP) Market Facts & Figures

  • 9.1 Japan Large Volume Parenteral (LVP) Sales by Company
    • 9.1.1 Japan Large Volume Parenteral (LVP) Sales by Company (2016-2021)
    • 9.1.2 Japan Large Volume Parenteral (LVP) Revenue by Company (2016-2021)
  • 9.2 Japan Large Volume Parenteral (LVP) Sales Breakdown by Type
    • 9.2.1 Japan Large Volume Parenteral (LVP) Sales Breakdown by Type (2016-2021)
    • 9.2.2 Japan Large Volume Parenteral (LVP) Sales Breakdown by Type (2022-2027)
  • 9.3 Japan Large Volume Parenteral (LVP) Sales Breakdown by Application
    • 9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
    • 9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Large Volume Parenteral (LVP) Market Facts & Figures

  • 10.1 Southeast Asia Large Volume Parenteral (LVP) Sales by Company
    • 10.1.1 Southeast Asia Large Volume Parenteral (LVP) Sales by Company (2016-2021)
    • 10.1.2 Southeast Asia Large Volume Parenteral (LVP) Revenue by Company (2016-2021)
  • 10.2 Southeast Asia Large Volume Parenteral (LVP) Sales Breakdown by Type
    • 10.2.1 Southeast Asia Large Volume Parenteral (LVP) Sales Breakdown by Type (2016-2021)
    • 10.2.2 Southeast Asia Large Volume Parenteral (LVP) Sales Breakdown by Type (2022-2027)
  • 10.3 Southeast Asia Large Volume Parenteral (LVP) Sales Breakdown by Application
    • 10.3.1 Southeast Asia M Units Sales Breakdown by Application (2016-2021)
    • 10.3.2 Southeast Asia M Units Sales Breakdown by Application (2022-2027)

11 India Large Volume Parenteral (LVP) Market Facts & Figures

  • 11.1 India Large Volume Parenteral (LVP) Sales by Company
    • 11.1.1 India Large Volume Parenteral (LVP) Sales by Company (2016-2021)
    • 11.1.2 India Large Volume Parenteral (LVP) Revenue by Company (2016-2021)
  • 11.2 India Large Volume Parenteral (LVP) Sales Breakdown by Type
    • 11.2.1 India Large Volume Parenteral (LVP) Sales Breakdown by Type (2016-2021)
    • 11.2.2 India Large Volume Parenteral (LVP) Sales Breakdown by Type (2022-2027)
  • 11.3 India Large Volume Parenteral (LVP) Sales Breakdown by Application
    • 11.3.1 India Large Volume Parenteral (LVP) Sales Breakdown by Application (2016-2021)
    • 11.3.2 India Large Volume Parenteral (LVP) Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Large Volume Parenteral (LVP) Business

  • 12.1 Baxter Healthcare
    • 12.1.1 Baxter Healthcare Corporation Information
    • 12.1.2 Baxter Healthcare Business Overview
    • 12.1.3 Baxter Healthcare Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
    • 12.1.4 Baxter Healthcare Large Volume Parenteral (LVP) Products Offered
    • 12.1.5 Baxter Healthcare Recent Development
  • 12.2 Kelun Pharma
    • 12.2.1 Kelun Pharma Corporation Information
    • 12.2.2 Kelun Pharma Business Overview
    • 12.2.3 Kelun Pharma Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
    • 12.2.4 Kelun Pharma Large Volume Parenteral (LVP) Products Offered
    • 12.2.5 Kelun Pharma Recent Development
  • 12.3 B. Braun
    • 12.3.1 B. Braun Corporation Information
    • 12.3.2 B. Braun Business Overview
    • 12.3.3 B. Braun Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
    • 12.3.4 B. Braun Large Volume Parenteral (LVP) Products Offered
    • 12.3.5 B. Braun Recent Development
  • 12.4 Fresenius
    • 12.4.1 Fresenius Corporation Information
    • 12.4.2 Fresenius Business Overview
    • 12.4.3 Fresenius Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
    • 12.4.4 Fresenius Large Volume Parenteral (LVP) Products Offered
    • 12.4.5 Fresenius Recent Development
  • 12.5 Teva Pharmaceutical Industries
    • 12.5.1 Teva Pharmaceutical Industries Corporation Information
    • 12.5.2 Teva Pharmaceutical Industries Business Overview
    • 12.5.3 Teva Pharmaceutical Industries Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
    • 12.5.4 Teva Pharmaceutical Industries Large Volume Parenteral (LVP) Products Offered
    • 12.5.5 Teva Pharmaceutical Industries Recent Development
  • 12.6 Pfizer (Hospira)
    • 12.6.1 Pfizer (Hospira) Corporation Information
    • 12.6.2 Pfizer (Hospira) Business Overview
    • 12.6.3 Pfizer (Hospira) Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
    • 12.6.4 Pfizer (Hospira) Large Volume Parenteral (LVP) Products Offered
    • 12.6.5 Pfizer (Hospira) Recent Development
  • 12.7 Ostuka Pharmaceutical
    • 12.7.1 Ostuka Pharmaceutical Corporation Information
    • 12.7.2 Ostuka Pharmaceutical Business Overview
    • 12.7.3 Ostuka Pharmaceutical Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
    • 12.7.4 Ostuka Pharmaceutical Large Volume Parenteral (LVP) Products Offered
    • 12.7.5 Ostuka Pharmaceutical Recent Development
  • 12.8 CR Double-Crane
    • 12.8.1 CR Double-Crane Corporation Information
    • 12.8.2 CR Double-Crane Business Overview
    • 12.8.3 CR Double-Crane Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
    • 12.8.4 CR Double-Crane Large Volume Parenteral (LVP) Products Offered
    • 12.8.5 CR Double-Crane Recent Development
  • 12.9 Pisa
    • 12.9.1 Pisa Corporation Information
    • 12.9.2 Pisa Business Overview
    • 12.9.3 Pisa Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
    • 12.9.4 Pisa Large Volume Parenteral (LVP) Products Offered
    • 12.9.5 Pisa Recent Development
  • 12.10 Huaren
    • 12.10.1 Huaren Corporation Information
    • 12.10.2 Huaren Business Overview
    • 12.10.3 Huaren Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
    • 12.10.4 Huaren Large Volume Parenteral (LVP) Products Offered
    • 12.10.5 Huaren Recent Development
  • 12.11 Patheon
    • 12.11.1 Patheon Corporation Information
    • 12.11.2 Patheon Business Overview
    • 12.11.3 Patheon Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
    • 12.11.4 Patheon Large Volume Parenteral (LVP) Products Offered
    • 12.11.5 Patheon Recent Development
  • 12.12 Aspen Holdings
    • 12.12.1 Aspen Holdings Corporation Information
    • 12.12.2 Aspen Holdings Business Overview
    • 12.12.3 Aspen Holdings Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
    • 12.12.4 Aspen Holdings Large Volume Parenteral (LVP) Products Offered
    • 12.12.5 Aspen Holdings Recent Development
  • 12.13 Beximco Pharma
    • 12.13.1 Beximco Pharma Corporation Information
    • 12.13.2 Beximco Pharma Business Overview
    • 12.13.3 Beximco Pharma Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
    • 12.13.4 Beximco Pharma Large Volume Parenteral (LVP) Products Offered
    • 12.13.5 Beximco Pharma Recent Development
  • 12.14 Cook Pharmica
    • 12.14.1 Cook Pharmica Corporation Information
    • 12.14.2 Cook Pharmica Business Overview
    • 12.14.3 Cook Pharmica Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
    • 12.14.4 Cook Pharmica Large Volume Parenteral (LVP) Products Offered
    • 12.14.5 Cook Pharmica Recent Development
  • 12.15 Albert David
    • 12.15.1 Albert David Corporation Information
    • 12.15.2 Albert David Business Overview
    • 12.15.3 Albert David Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
    • 12.15.4 Albert David Large Volume Parenteral (LVP) Products Offered
    • 12.15.5 Albert David Recent Development
  • 12.16 PSI Ltd
    • 12.16.1 PSI Ltd Corporation Information
    • 12.16.2 PSI Ltd Business Overview
    • 12.16.3 PSI Ltd Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
    • 12.16.4 PSI Ltd Large Volume Parenteral (LVP) Products Offered
    • 12.16.5 PSI Ltd Recent Development
  • 12.17 Ozon Pharmaceuticals
    • 12.17.1 Ozon Pharmaceuticals Corporation Information
    • 12.17.2 Ozon Pharmaceuticals Business Overview
    • 12.17.3 Ozon Pharmaceuticals Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
    • 12.17.4 Ozon Pharmaceuticals Large Volume Parenteral (LVP) Products Offered
    • 12.17.5 Ozon Pharmaceuticals Recent Development
  • 12.18 BAG Healthcare
    • 12.18.1 BAG Healthcare Corporation Information
    • 12.18.2 BAG Healthcare Business Overview
    • 12.18.3 BAG Healthcare Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
    • 12.18.4 BAG Healthcare Large Volume Parenteral (LVP) Products Offered
    • 12.18.5 BAG Healthcare Recent Development
  • 12.19 BML Parenteral Drugs
    • 12.19.1 BML Parenteral Drugs Corporation Information
    • 12.19.2 BML Parenteral Drugs Business Overview
    • 12.19.3 BML Parenteral Drugs Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
    • 12.19.4 BML Parenteral Drugs Large Volume Parenteral (LVP) Products Offered
    • 12.19.5 BML Parenteral Drugs Recent Development

13 Large Volume Parenteral (LVP) Manufacturing Cost Analysis

  • 13.1 Large Volume Parenteral (LVP) Key Raw Materials Analysis
    • 13.1.1 Key Raw Materials
    • 13.1.2 Key Raw Materials Price Trend
    • 13.1.3 Key Suppliers of Raw Materials
  • 13.2 Proportion of Manufacturing Cost Structure
  • 13.3 Manufacturing Process Analysis of Large Volume Parenteral (LVP)
  • 13.4 Large Volume Parenteral (LVP) Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

  • 14.1 Marketing Channel
  • 14.2 Large Volume Parenteral (LVP) Distributors List
  • 14.3 Large Volume Parenteral (LVP) Customers

15 Market Dynamics

  • 15.1 Large Volume Parenteral (LVP) Market Trends
  • 15.2 Large Volume Parenteral (LVP) Drivers
  • 15.3 Large Volume Parenteral (LVP) Market Challenges
  • 15.4 Large Volume Parenteral (LVP) Market Restraints

16 Research Findings and Conclusion

    17 Appendix

    • 17.1 Research Methodology
      • 17.1.1 Methodology/Research Approach
      • 17.1.2 Data Source
    • 17.2 Author List

    Summary:
    Get latest Market Research Reports on Large Volume Parenteral (LVP) . Industry analysis & Market Report on Large Volume Parenteral (LVP) is a syndicated market report, published as Global Large Volume Parenteral (LVP) Sales Market Report 2021. It is complete Research Study and Industry Analysis of Large Volume Parenteral (LVP) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$4,000.00
    		$6,000.00
    		$8,000.00
    		3,240.00
    		4,860.00
    		6,480.00
    		3,756.00
    		5,634.00
    		7,512.00
    		619,040.00
    		928,560.00
    		1,238,080.00
    		333,600.00
    		500,400.00
    		667,200.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo